Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126636) titled 'Study on the Mechanism of SRPK1 Regulating Ferroptosis to promote trastuzumab Resistance in HER2+ Breast Cancer' on June 12.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Condition:
Malignant tumor of the breast
Intervention:
Observation Group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-20
Target Sample Size: Observation Group:10;Control group:10;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.ht...